Nihal Sinha - Partner @ F-Prime - Crunchbase Person Profile

Start Free Trial

Pricing

Overview

Number of Current Board & Advisor Roles

CB Rank (Investor)

65,286

Primary Job Title Partner
Primary Organization
F-Prime

Location London, England, United Kingdom
Regions Europe, Middle East, and Africa (EMEA)
Gender Male

Investor Type
obfuscated
obfuscation

LinkedIn View on LinkedIn

Nihal Sinha is based out of London, England and is the Partner of F-Prime. Nihal previously worked at The Boston Consulting Group as a Management Consultant. Nihal Sinha attended the University of Cambridge.

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Immutrin	F-Prime	—	Series A - Immutrin	obfuscated obfuscation
obfuscated obfuscation	T-Therapeutics	F-Prime	—	Series A - T-Therapeutics	obfuscated obfuscation
obfuscated obfuscation	CHARM Therapeutics	F-Prime	—	Series B - CHARM Therapeutics	obfuscated obfuscation
obfuscated obfuscation	AvenCell	F-Prime	—	Series B - AvenCell	obfuscated obfuscation
obfuscated obfuscation	T-Therapeutics	F-Prime	Yes	Series A - T-Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Elucidata	F-Prime	—	Series A - Elucidata	obfuscated obfuscation
obfuscated obfuscation	RIGImmune	F-Prime	Yes	Seed Round - RIGImmune	obfuscated obfuscation
obfuscated obfuscation	CHARM Therapeutics	F-Prime	Yes	Series A - CHARM Therapeutics	obfuscated obfuscation

Jobs

Number of Current Jobs

Number of Past Jobs

Nihal Sinha

is the

Partner

F-Prime

. Additionally,

Nihal Sinha

has had

past jobs including

Member of the Founding Team

Orchard Therapeutics

F-Prime PartnerNov 2014

Organization Name	Title At Company	Start Date	End Date
Orchard Therapeutics	Member of the Founding Team	May 2016	Jan 2019
F-Prime	Senior Associate	—	—

Board and Advisor Roles

Number of Current Board & Advisor Roles

Nihal Sinha

holds

board and advisor roles including

Board Member

Immutrin

Board Member

T-Therapeutics

, and

Board Member

RIGImmune

Immutrin Board MemberMar 2026
T-Therapeutics Board MemberJan 2023
RIGImmune Board MemberSep 2022
CHARM Therapeutics Board MemberOct 2021

Related Hubs

Hub Name	CB Rank (Hub)
Venture Stage Investors with Investments in London, England	7,280
Late Stage Venture Investors with Investments in United Kingdom	4,028
Early Stage Venture Investors with Investments in Europe, Middle East, and Africa (EMEA)	8,422
Venture Stage Investors with Investments in United Kingdom	6,420
Seed Stage Investors with Investments in England	4,286
Early Stage Venture Investors with Investments in Europe (Top 10K)	1,400
Investors Active in United Kingdom (Top 10K)	850
Venture Stage Investors with Investments in England	7,166
Venture Capital Investors with Investments in London, England	2,574
Late Stage Venture Investors with Investments in London, England	4,977

Education

Nihal Sinha

studied at

University of Cambridge

and

University of Cambridge

University of Cambridge MB BChirMedicine20022008
University of Cambridge MAPhysiology and Psychology20022005

Recent News and Activity

There is no recent news or activity for this profile.